Glen Stettin

Glen Stettin

Corporate Officer/Principal at EXPRESS SCRIPTS HOLDING CO
62 year
Retail Trade
Consumer Services
Commercial Services

Profile

Glen D.
Stettin
is Senior VP-Clinical, Research & New Solutions at Express Scripts, Inc. since 2012.
Dr. Stettin is Chief Innovation Officer & Senior VP-Research at Evernorth Health, Inc. since 2012.
Dr. Stettin was Independent Director at PRA Health Sciences, Inc. from 2020 to 2021.
Dr. Stettin was Director at MedAvail, Inc. from 2018 to 2022.
Dr. Stettin was Independent Director at MedAvail Holdings, Inc. from 2020 to 2024.
Dr. Stettin was Chief Medical Officer & Senior Vice President at Medco Health Solutions, Inc. from 2010 to 2012.
Dr. Stettin completed undergraduate studies at Lehigh University.
Dr. Stettin earned a doctorate from Drexel University College of Medicine.

Glen Stettin active positions

CompaniesPositionStart
EXPRESS SCRIPTS HOLDING CO Corporate Officer/Principal 01/04/2012
Chief Tech/Sci/R&D Officer 05/07/2012

Former positions of Glen Stettin

CompaniesPositionEnd
MEDAVAIL HOLDINGS, INC. Director/Board Member 20/03/2024
Director/Board Member 01/02/2022
PRA HEALTH SCIENCES, INC. Director/Board Member 01/07/2021
Chief Tech/Sci/R&D Officer 01/04/2012
See the detail of Glen Stettin's experience

Training of Glen Stettin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

57

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Retail Trade

Commercial Services

Health Services

Finance

Consumer Services

Consumer Services

Technology Services

Retail Trade

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!